AI assistant
PFIZER INC — Director's Dealing 2022
Feb 26, 2022
29831_dirs_2022-02-25_5e92f2de-a3b6-4569-a831-21b95d0b43c3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2022-02-23
Reporting Person: Dolsten Mikael (President R&D)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-23 | Common Stock | F | 29767.0000 | $46.8700 | Disposed | 323862.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-24 | Stock Appreciation Rights | $45.9600 | A | 126794.0000 | Acquired | 2027-02-24 | Common Stock (126794.0000) | Direct |
| 2022-02-24 | Stock Appreciation Rights | $45.9600 | A | 111516.0000 | Acquired | 2029-02-24 | Common Stock (111516.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1817.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).
F2: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F3: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.